Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Provocative testing of the pulmonary circulation: advances and unresolved issues

Edmund M. Lau, Robert Naeije
European Respiratory Journal 2016 48: 18-20; DOI: 10.1183/13993003.00860-2016
Edmund M. Lau
1University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Naeije
2University of Brussels, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rnaeije@ulb.ac.be
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Expert consensus standardisation of provocative testing of the pulmonary circulation is needed http://ow.ly/4nsNbU

In this issue of the European Respiratory Journal, Oliveira et al. [1] from Harvard Medical School (Boston, MA, USA) report on rapid recovery of pulmonary vascular pressures after maximum incremental cycling exercise. The authors combined right heart catheterisation with concurrent cardiopulmonary exercise test in 95 patients referred for unexplained dyspnoea. 36 patients had precapillary pulmonary hypertension (PH) during exercise, defined by the authors as displaying a peak exercise mean pulmonary artery pressure (mPAP) ≥30 mmHg, a peak wedged pulmonary artery pressure (PAWP) <20 mmHg and a peak pulmonary vascular resistance (PVR) ≥1.5 Wood units (WU). 28 patients had postcapillary PH during exercise defined by a peak PAWP ≥20 mmHg. 31 matched controls with normal resting mPAP were selected based on a maximum oxygen uptake ≥80% predicted in the absence of exercise PH based on the aforementioned criteria. Workload and oxygen uptake at the ventilatory threshold and at peak exercise were lower in the exercise PH patients, which confirm the relevance of exercise pulmonary haemodynamic measurements in unexplained dyspnoea. However, most of the exercise-induced increase in PAWP and mPAP was reversed within 2 min of recovery. The important message is that pulmonary haemodynamics have to be measured during, but not after, an exercise stress test for the diagnosis of exercise PH.

Provocative testing is used in many areas of medicine to uncover early-stage pathology. However, regarding early or latent PH, experts remain utterly cautious. Reports and guidelines derived from the last World Symposium held in Nice (France) in 2013 state that exercise stress testing or volume loading of the pulmonary circulation is not encouraged because of insufficient evidence about the limits of normal and prognostic or therapeutic implications [2, 3]. Yet the practice has been around since the early times of cardiac catheterisation [4] and significant progress has been made in recent years [5].

It is now well established that the upper limit of normal of mPAP during exercise is 30 mmHg at a cardiac output (CO) <10 L·min−1, which corresponds to a total pulmonary vascular resistance (TPR) (or mPAP/CO) of 3 WU [5–9]. Meaningful noninvasive measurements are being reported by dedicated groups [5–7]. Furthermore, evidence is being gathered that higher than normal pulmonary artery pressure during exercise may be the cause of otherwise unexplained dyspnoea and may facilitate the early diagnosis of PH secondary to respiratory or left heart conditions [6, 7].

The cause of exercise PH is either an upstream transmission of increased PAWP, such as in heart failure with preserved or reduced ejection and left heart valvulopathies, or an increase in PVR, such as in pulmonary vascular disease, hypoxia or disturbed lung mechanics [4–8]. This differential diagnosis is often clinically straightforward, but precise measurement and interpretation of PAWP or left ventricular end-diastolic pressure measurements is paramount. The upper limit of normal of PAWP during exercise is generally thought to be between 15 and 20 mmHg but higher values can be recorded in athletes and in elderly subjects [10]. Oliveira et al. [1] considered 20 mmHg as a reasonable upper limit of normal. However, a higher cut-off value of 25 mmHg has been proposed for the diagnosis of heart failure [11, 12]. Likewise, for mPAP, a flow-corrected measure may be more appropriate. As TPR decreases during exercise by up to 25% [10], it is easy to predict normal PAWP/CO slopes of <2 mmHg·L−1·min−1. This has indeed been measured but in limited size healthy control groups [11–13].

It is interesting that Oliveira et al. [1] consider PVR instead of TPR combined to increased pulmonary artery pressure in the diagnosis of exercise PH and actually retain a cut-off value of 1.5 WU [1]. This PVR cut-off seems low, since a significant proportion of patients based on these criteria may not exceed a mPAP >30 mmHg together with TPR >3 WU during exercise. Definitions of PH have traditionally incorporated a “safety margin” to decrease the prevalence of false positives due to healthy outliers and lack of precision of measurements. This is why PH is defined by a mPAP >25 mmHg at rest, while the upper limit of normal is 20 mmHg. One still does not know if a mPAP >30 mmHg at a CO <10 L·min−1, corresponding to a TPR of 3 WU is enough to minimise false positives across different ethnic populations and age groups. Conversely, the incorporation of a safety margin may also increase the likelihood of false-negative cases. In other words, any diagnostic thresholds assume a trade-off between sensitivity and specificity. For example, there was a recent noninvasive study showing higher exercise TPR values between 3 and 3.5 WU encountered in healthy sub-Saharan black African males [14]. An exercise TPR slightly above 3 WU is also sometimes measured in invasively explored European healthy controls [8].

Measurements of pulmonary artery pressure and PAWP during exercise are technically challenging and are complicated by intrathoracic pressure swings [15]. It may then be advised to average the reading of pulmonary vascular pressure curves over several respiratory cycles instead of only at end-expiration [2]. This was actually done by Oliveira et al. [1] and the most recently updated European Respiratory Society/European Society of Cardiology guidelines agree [3]. However, doubt remains about when to switch from one method to the other, and how relevant this is to symptoms and outcome.

Another increasingly popular stress test of the pulmonary circulation is fluid loading, which is mainly used to detect latent pulmonary venous hypertension in left heart diseases. Thus, any condition associated with altered left ventricular diastolic compliance or mitral valve stenosis will be associated with a rapid increase in PAWP when challenged with an increased systemic venous return [16]. Here also there has been debate about how to standardise a fluid challenge and what cut-off values for PAWP to consider. Fluid loading increases PAWP in healthy volunteers as a function of age, sex, amount infused and infusion rate [17]. While there is an emerging consensus to infuse 500 mL of saline in 5–10 min, some groups consider a PAWP of 15 mmHg as a reasonable cut-off for a pathological response [18, 19]. However, a re-analysis of existing data gathered in healthy subjects and accumulating clinical experience [20] is drifting this cut-off value to 20 mmHg. It should not be overlooked that exercise increases systemic venous return as well. However, exercise may be more sensitive than volume loading to detect early pulmonary venous hypertension in patients with heart failure with preserved ejection fraction [21].

Where do we go from here? The report by Oliveira et al. [1] is an important step forward for the standardisation of provocative testing of the right ventricular–pulmonary circulation unit, but a lot remains to be done. While it is hopefully agreed that any test requires measurements while the system of interest is stressed, there are a series of other methodological issues that will require expert consensus standardisation. One of those may be body position, as some exercise tests are performed with the subject sitting on a bicycle, others in a tilted armchair convenient for echocardiography and others simply in the recumbent position of a catheterisation laboratory table. Body position certainly affects resting pulmonary haemodynamics since upright posture is associated with pulmonary vascular decruitment and reduced systemic venous return. However, body position is probably less important for exercise measurements, but more data are certainly needed. The exercise modality also matters, as a resistive component may be associated with an increased systemic vascular resistance or an increased intrathoracic pressure on Valsalva manoeuver, all affecting directly or indirectly pulmonary vascular pressures. Some centres measure mPAP as a function of workload, which is linearly related to CO but cannot be considered as a surrogate, as the range of CO responses to a given workload varies considerably [22]. One of the most urgent questions is that of end-expiratory versus average reading of pulmonary vascular pressure curves. Last but not least, there is a need for more validation of noninvasive approaches, as cardiac catheterisation cannot be generally used for screening or detection of early disease in minimally symptomatic patients.

In the meantime, Oliveira et al. [1] are to be congratulated for moving forward with extremely difficult experiments combining cardiac catheterisation and exercise testing. It is fascinating that there are still so many physiological questions to address for a better understanding and early diagnosis of different forms PH, and that colleagues are ready to roll up their sleeves to solve still-pending methodological issues. No medical advance is possible without undisputed methodology.

Footnotes

  • Conflict of interest: None declared.

  • Received April 30, 2016.
  • Accepted May 3, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Oliveira RKF,
    2. Waxman AB,
    3. Agarwal M, et al.
    Pulmonary haemodynamics during recovery from maximum incremental cycling exercise. Eur Respir J 2016; 48: 158–167.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hoeper MM, et al.
    Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D45–D50.
    OpenUrl
  3. ↵
    1. Galiè N,
    2. Humbert M,
    3. Vachiery J-L, et al.
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903–975.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Wood P
    . Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J 1958; 20: 557–570.
    OpenUrlFREE Full Text
  5. ↵
    1. Naeije R,
    2. Vonk Noordegraaf A,
    3. Kovacs G
    . Exercise-induced pulmonary hypertension: at last! Eur Respir J 2015; 46: 583–586.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Naeije R,
    2. Vanderpool R,
    3. Dhakal BP, et al.
    Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 2013; 187: 576–583.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Lewis GD,
    2. Bossone E,
    3. Naeije R, et al.
    Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 2013; 128: 1470–1479.
    OpenUrlFREE Full Text
  8. ↵
    1. Herve P,
    2. Lau EM,
    3. Sitbon O, et al.
    Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J 2015; 46: 728–737.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Kovacs G,
    2. Avian A,
    3. Olschewski H
    . Proposed new definition of exercise pulmonary hypertension decreases false-positive cases. Eur Respir J 2016; 47: 1270–1273.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Kovacs G,
    2. Olschewski A,
    3. Berghold A, et al.
    Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 2012; 39: 319–328.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Borlaug BA,
    2. Nishimura RA,
    3. Sorajja P, et al.
    Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588–595.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Andersen MJ, et al.
    Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction. Circ Heart Fail 2012; 5: 444–451.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Kovacs G,
    2. Olschewski A,
    3. Berghold A, et al.
    Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 2012; 39: 319–328.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Simaga B,
    2. Vicenzi M,
    3. Faoro V, et al.
    Pulmonary vascular function and exercise capacity in black sub-Saharan Africans. J Appl Physiol 2015; 119: 502–507.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Kovacs G,
    2. Avian A,
    3. Pienn M, et al.
    Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014; 190: 252–257.
    OpenUrlPubMed
  16. ↵
    1. Andersen MJ,
    2. Hwang SJ,
    3. Kane GC, et al.
    Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Circ Heart Fail 2015; 8: 542–550.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Borlaug BA
    . Invasive assessment of pulmonary hypertension. Time for a more fluid approach? Circ Heart Fail 2014; 7: 2–4.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Fujimoto N,
    2. Borlaug BA,
    3. Lewis GD, et al.
    Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 2013; 127: 55–62.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Fox BD,
    2. Shimony A,
    3. Langleben D, et al.
    High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013; 42: 1083–1091.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Robbins IM,
    2. Hemnes AR,
    3. Pugh ME, et al.
    High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014; 7: 116–122.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Andersen MJ,
    2. Olson TP,
    3. Melenovsky V, et al.
    Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail 2015; 8: 41–48.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Argiento P,
    2. Vanderpool RR,
    3. Mule M, et al.
    Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest 2012; 590: 4279–4288.
    OpenUrl
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 1 Table of Contents
European Respiratory Journal: 48 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Provocative testing of the pulmonary circulation: advances and unresolved issues
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Provocative testing of the pulmonary circulation: advances and unresolved issues
Edmund M. Lau, Robert Naeije
European Respiratory Journal Jul 2016, 48 (1) 18-20; DOI: 10.1183/13993003.00860-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Provocative testing of the pulmonary circulation: advances and unresolved issues
Edmund M. Lau, Robert Naeije
European Respiratory Journal Jul 2016, 48 (1) 18-20; DOI: 10.1183/13993003.00860-2016
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • ERS Tobacco Control Committee statement on Tobacco 21
  • Inflammatory biomarkers in PAH and clinical implementation?
  • NSAIDs, respiratory disease, dupilumab and aspirin tolerance
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society